11-Year-Old MN Boy Only Second in U.S. to get Tzield for Type 1 Diabetes | Sanford Health News

For the 14th straight day, Joseph Rubash is headed to a hospital room at Sanford Bemidji. He is an 11-year-old boy who brightens the day of every person who comes in contact with him.
“He’s a real loving boy,” said Brenda Rubash, Joseph’s mother. “He loves to hug and tell us that he loves us, and he’s really gregarious and outgoing.”
Read the full story: news.sanfordhe...
Subscribe for more stories: san.fo/2EuFiCY
Visit our Sanford Health Facebook page: / sanfordhealth
Follow us on Twitter: / sanfordhealth
Follow @SanfordHealth on Instagram: / sanfordhealth
Connect with us on LinkedIn: linkedin.com/company/sanford-health/

[@clintharris6468]

What a great treatment! Wish this was available years ago.

[@SatoshiNakamoto01]

Whats its for

[@sanfordhealth]

Hello! Tzield binds to certain immune system cells and delays progression to stage 3 type 1 diabetes. Tzield may deactivate the immune cells that attack insulin-producing cells, while increasing the proportion of cells that help moderate the immune response.